These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 33669643)

  • 21. Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model.
    Melo LDR; Ferreira R; Costa AR; Oliveira H; Azeredo J
    Sci Rep; 2019 Apr; 9(1):6643. PubMed ID: 31040333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections.
    Uchiyama J; Rashel M; Takemura I; Wakiguchi H; Matsuzaki S
    Appl Environ Microbiol; 2008 Jul; 74(13):4149-63. PubMed ID: 18456848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.
    Chatterjee A; Johnson CN; Luong P; Hullahalli K; McBride SW; Schubert AM; Palmer KL; Carlson PE; Duerkop BA
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936157
    [No Abstract]   [Full Text] [Related]  

  • 24. The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains.
    D'Andrea MM; Frezza D; Romano E; Marmo P; Henrici De Angelis L; Perini N; Thaller MC; Di Lallo G
    J Glob Antimicrob Resist; 2020 Jun; 21():68-75. PubMed ID: 31678321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin.
    Zhang W; Mi Z; Yin X; Fan H; An X; Zhang Z; Chen J; Tong Y
    PLoS One; 2013; 8(11):e80435. PubMed ID: 24236180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete genome analysis of the novel Enterococcus faecalis phage vB_EfaS_AL3.
    Yuan Y; Zhao F; Wang L; Tan D; Cong C; Li X; Xu Y
    Arch Virol; 2019 Oct; 164(10):2599-2603. PubMed ID: 31278422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Phage Therapy in the Context of
    Bolocan AS; Upadrasta A; Bettio PHA; Clooney AG; Draper LA; Ross RP; Hill C
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31010053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological characteristics and genome analysis of a novel phage vB_KpnP_IME279 infecting Klebsiella pneumoniae.
    Zhang R; Zhao F; Wang J; Pei G; Fan H; Zhangxiang L; Mi Z; Shi T; Liu H; Tong Y
    Folia Microbiol (Praha); 2020 Dec; 65(6):925-936. PubMed ID: 33064268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Kishimoto T; Ishida W; Fukuda K; Nakajima I; Suzuki T; Uchiyama J; Matsuzaki S; Todokoro D; Daibata M; Fukushima A
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete genome sequence of bacteriophage BC-611 specifically infecting Enterococcus faecalis strain NP-10011.
    Horiuchi T; Sakka M; Hayashi A; Shimada T; Kimura T; Sakka K
    J Virol; 2012 Sep; 86(17):9538-9. PubMed ID: 22879611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a Lytic Bacteriophage vB_EfaS_PHB08 Harboring Endolysin Lys08 Against
    Yang D; Chen Y; Sun E; Hua L; Peng Z; Wu B
    Microorganisms; 2020 Aug; 8(9):. PubMed ID: 32878334
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of Four New
    Di Lallo G; Falconi M; Iacovelli F; Frezza D; D'Addabbo P
    Phage (New Rochelle); 2021 Sep; 2(3):131-141. PubMed ID: 36161247
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel lytic bacteriophage vB_GEC_EfS_9 against Enterococcus faecium.
    Rigvava S; Kusradze I; Tchgkonia I; Karumidze N; Dvalidze T; Goderdzishvili M
    Virus Res; 2022 Jan; 307():198599. PubMed ID: 34648886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation, characterization and complete genome analysis of a novel bacteriophage vB_EfaS-SRH2 against Enterococcus faecalis isolated from periodontitis patients.
    Pazhouhnia S; Bouzari M; Arbabzadeh-Zavareh F
    Sci Rep; 2022 Aug; 12(1):13268. PubMed ID: 35918375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages.
    Yasmin A; Kenny JG; Shankar J; Darby AC; Hall N; Edwards C; Horsburgh MJ
    J Bacteriol; 2010 Feb; 192(4):1122-30. PubMed ID: 20008075
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Huang L; Guo W; Lu J; Pan W; Song F; Wang P
    Front Microbiol; 2022; 13():866382. PubMed ID: 35432223
    [No Abstract]   [Full Text] [Related]  

  • 37. The Novel
    Lee D; Im J; Na H; Ryu S; Yun CH; Han SH
    Front Microbiol; 2019; 10():2877. PubMed ID: 31921055
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of φEf-vB1 prophage infecting oral
    Askora A; El-Telbany M; El-Didamony G; Ariny E; Askoura M
    J Med Microbiol; 2020 Sep; 69(9):1151-1168. PubMed ID: 32840477
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of an
    Song F; Sheng J; Tan J; Xie H; Wang X; Guo W
    Front Microbiol; 2023; 14():1210319. PubMed ID: 37426023
    [No Abstract]   [Full Text] [Related]  

  • 40. Phage therapy: A renewed approach against oral diseases caused by Enterococcus faecalis infections.
    Yang D; Xiang Y; Song F; Li H; Ji X
    Microb Pathog; 2024 Apr; 189():106574. PubMed ID: 38354990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.